Guided Placement of CRT-Leads (EK138/08)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00764075|
Recruitment Status : Completed
First Posted : October 1, 2008
Last Update Posted : July 7, 2011
|Condition or disease||Intervention/treatment||Phase|
|Heart Failure||Device: Beutel TM Other: standard Device: software Beutel TM||Not Applicable|
Patients will be allocated to two groups with either
- Guided implantation of the left ventricular lead
- Empirical implantation of the left ventricular lead (current clinical standard)
For Treatment Group a) the target vessel, which is the vessel with smallest distance between RLC and CVS is determined in advance and provided to the implanting physician. In case, this vessel is not amenable for lead positioning, a second vessel which is the second closest to the RLC is defined.
For Treatment Group b), the physician has to choose the vessel where to place the electrode without knowing the exact spatial orientation between that particular side-branch and the RLC.
In all patients, standard biventricular devices and leads are to be used. Aspects that are evaluated are:
- Technical success in placing the electrode in the target vessel.
- Failure due to dislocation during the implantation procedure or phrenic nerve stimulation.
Also, procedure duration, radiation exposure, and complications occurring during the procedure as well as post- operatively will be documented.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||132 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||CT and 3D-Echocardiography Placement of CRT-Leads|
|Study Start Date :||October 2008|
|Actual Primary Completion Date :||April 2011|
|Actual Study Completion Date :||June 2011|
guided implantation of the left ventricular lead
Device: Beutel TM
application of BeutelTM
Placebo Comparator: 2
standard implantation of the left ventricular lead
standard procedure will be applied but no Beutel TM software
Experimental: Pilot Group
feasibility of guided placement of CRT-leads in 20 Patients
Device: software Beutel TM
application of BeutelTM to patients data for determination of site of latest contraction
- Rate of non-responders regarding ejection fraction [ Time Frame: 6 months ]
- rate of non-responders regarding NYHA-classification, left end-diastolic and end-systolic volume [ Time Frame: 6 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00764075
|Department of Medicine, Division of Cardiology, Pulmonology and Vascular Medicine|
|Aachen, NRW, Germany, 52074|
|Principal Investigator:||Christian Knackstedt, MD||RWTH Aachen University Departement of Cardiology, Pulmonology and Vascular Medicine|